1st January 2023
TYDOCK PHARMA works with highly dynamic structure and a collaborative spirit. Since the company was set up, we have established many strong collaborations with universities, independent research centers, companies and researchers. Our strength is the ability to work in multidisciplinary networks to innovate.
Relevant collaborations:
- École Polytechnique Fédérale de Lausanne (EPFL), Switzerland
- University of Pavia, Italy
- University of Cambridge, UK
- Institut Pasteur (Pasteur), France
- University of Cape Town, South Africa
- INSERM/Institut Pasteur of Lille, France
- University of Modena e Reggio Emilia, Italy
- Bernhard Nocht Institute for Tropical Medicine (BNI), Germany
- Centro Nacional de Pesquisa em Energia e Materiais (CNPEM), Brazil
- Ethniko Idryma Erevnon (NHRF), Greece
- Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Germany
- Instituto de Biologia Molecular e Celular (IBMC), Portugal
- National Center for Research Universidad Complutense de Madrid, Spain
- National Center for Research (NCR), North Sudan
- University of Siena, Italy
- European Screening Port (ESP), Germany
- Heidelberg Institute for Theoretical Studies (HITS), Germany
- Hypha Discovery ltd, UK
- Interface Europe ltd, Belgium
- OPHERA srl, Italy
- Molecular Discovery ltd, UK
- Optosmart srl, Italy
- Institute of Composite and Biomedical Material of the Research National Council, Portici Italy
- Centro Regionale Information Communication Technology scrl, Benevento Italy
- Agencia Estatal Consejo Superior de Investigaciones Cientificas, Spain
- Proyeccion Europlan XXI S.L, Spain
- Confindustria Emilia-Romagna, Italy
- INESCOP, Centre for Technology and innovation, Spain
- DTI Danish Tecnological Institute, Denmark
- AMEK Srl, Italy
- Carnad Natural Test, Danmark
- Biolchim S.p.A., Italy
